AI
Saturday, September 09, 2017 11:13:28 AM
ouch. Yes, you're right, PFS
... and not median OS. T'was late and I rather scrambled with cutting down the title. Incidentally, if I understand correctly the "OS data were immature" means they are still blinded.
Just btw, the FDA (obviously) had a chance to take a look at the results a month earlier and perhaps the BTD should have made everybody at least a little suspicious about the interim results presented today
https://www.astrazeneca.com/media-centre/press-releases/2017/imfinzi-granted-breakthrough-therapy-designation-by-us-fda-for-patients-with-locally-advanced-unresectable-non-small-cell-lung-cancer-31072017.html
... and not median OS. T'was late and I rather scrambled with cutting down the title. Incidentally, if I understand correctly the "OS data were immature" means they are still blinded.
Just btw, the FDA (obviously) had a chance to take a look at the results a month earlier and perhaps the BTD should have made everybody at least a little suspicious about the interim results presented today
https://www.astrazeneca.com/media-centre/press-releases/2017/imfinzi-granted-breakthrough-therapy-designation-by-us-fda-for-patients-with-locally-advanced-unresectable-non-small-cell-lung-cancer-31072017.html
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
